Non-type 1 and non-type 2 diabetes in a young man due to novel mutation in HNF1A

Maturity-onset diabetes of the young (MODY) is an autosomal dominant monogenic form of diabetes. This report describes a case with hepatocyte nuclear factor 1-alpha (<i>HNF1A</i>)-MODY due to a novel heterozygous <i>HNF1A</i> mutation. The patient presented with hyperglycaemia and glycosuria in the absence of diabetic ketoacidosis. Family history was notable for early-onset diabetes. Genetic testing confirmed a previously unreported pathogenic <i>HNF1A</i> variant. Treatment with a GLP-1 receptor agonist and metformin reduced glycated haemoglobin from 10.2% to 6.0% within 3 months. This case highlights the importance of genetic screening in early-onset diabetes, which is frequently misdiagnosed as type 1 or type 2 diabetes, and expands the spectrum of <i>HNF1A</i> mutations relevant to precision medicine.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2025-12-01
DOI
https://doi.org/10.1136/bcr-2025-265503
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-type 1 and non-type 2 diabetes in a young man due to novel mutation in HNF1A

Yi‐Jen Hung, Sheng‐Chiang Su, Y.-C. Liu, Yen‐Lin Chen et al.
BMJ Case Reports
Pancreatic function and diabetes
article

Non-type 1 and non-type 2 diabetes in a young man due to novel mutation in HNF1A

Yi‐Jen Hung, Sheng‐Chiang Su, Y.-C. Liu, Yen‐Lin Chen, Feng-Chih Kuo
article en

Abstract

Maturity-onset diabetes of the young (MODY) is an autosomal dominant monogenic form of diabetes. This report describes a case with hepatocyte nuclear factor 1-alpha (<i>HNF1A</i>)-MODY due to a novel heterozygous <i>HNF1A</i> mutation. The patient presented with hyperglycaemia and glycosuria in the absence of diabetic ketoacidosis. Family history was notable for early-onset diabetes. Genetic testing confirmed a previously unreported pathogenic <i>HNF1A</i> variant. Treatment with a GLP-1 receptor agonist and metformin reduced glycated haemoglobin from 10.2% to 6.0% within 3 months. This case highlights the importance of genetic screening in early-onset diabetes, which is frequently misdiagnosed as type 1 or type 2 diabetes, and expands the spectrum of <i>HNF1A</i> mutations relevant to precision medicine.

BMJ Case ReportsVol. 18(12)
National Defense Medical Center (TW)
Openalex Percentile: Top 40%
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.